Berkshire Innovation Center’s Post

Save the Date for next week's webinar discussing insights into exoskeletons, standardization, and future trends. 🚀

Join us at Boston BioMed Booth #450 on September 20th and 21st to explore how our Advantage Pulsed Field Ablation Development Platform can give you a head start on your device development journey! We're diving deep into:  ✅ Accelerated Device Development  ✅ Customizable Solutions  ✅ An Expert Advantage    Don't miss this chance to transform your development journey!   #BostonBioMed #DeviceDevelopment #Innovation #MedTech #MedicalDevices #MedDevice #RegulatoryAffairs #MedDeviceStartup 

Want to learn more about Southern California's life science industry, and its impact on patients and the economy? Come to Biocom California's July 18 Greater LA Life Science Forum to learn from industry leaders, investors, and elected officials. Hope to see you there! #lifescience #biopharma #biotech #laeconomy

Common needs amongst medical device manufacturers I’ve worked with: ⏱️“I need to revolutionize the way we prototype, that means iteration and testing completed within hours, not weeks or days.” 💵“I need consistency within our high precision surgical applications without breaking the bank on high-cost industrial micro printing or micro injection molding.” Booth 🔸3399🔸 Talk with our manufacturing experts who can share how they’re implementing high precision 3D printing technology with real case studies. B9Creations | Digital Manufacturing Technology #MDMWest #medicaldevicemanufacturing #medicaldevice

Replicability is critical to science. I was reminded of this by a client project I recently worked on. The client reached out to our Market Intelligence team at LSI - Life Science Intelligence™ seeking to understand volumes and US market size estimates for drug-coated balloons (DCBs) used to restore blood flow in the peripheral arteries. In the analysis, we came across some interesting findings. The market for peripheral DCBs was severely hindered in 2019 as a result of a single systematic review and meta-analysis. The study itself produced some alarming results that saw an urgent response from regulatory bodies. While the rapid response of device manufacturers and regulatory bodies is appreciated as to not put patient lives at risk, the failure of additional studies to reproduce the original findings highlights the importance of replicability in scientific research. The devices in question offer significant clinical benefits to patients – a finding that was reinforced by additional studies following the 2018 meta-analysis. Replicability is critical to science. The statement bears repeating because drastic changes in healthcare — and by extension, society — should be made with confidence. That’s why I’m proud that the work we do at LSI (using Medtech Pro, by LSI) continues to support Medtech, Life Science, and Professional Services organizations in making their biggest strategic decisions with confidence. #medtech #marketresearch

Wow, LSI was extremely promising and exciting! Big thanks to Joe McClung for shedding light on some of the new, up and coming technologies in the #medtech space! Did you happen to attend LSI as well? Comment below with your favorite innovations. #medicaldevice #healthcareadvances #changinglives #innovation #technology

Do you want your Disruptive Technology to be recognized by Diagnostics & Laboratory Medicine community? Apply for #DTAC and get a chance at global exposure to the field and investors at #ADLM2024 in Chicago. Feedback, guidance and coaching at all stages of competition provided. Link below. Hard deadline: February 22. #disruptivetechnologies #innovation #award #pitch #pitchcompetition #diagnostics #laboratory #medicine

Looking forward to DeviceTalks Boston Wed/Thu this week, should be a great conference. Hit me up if you're attending, would love to connect. There are many interesting themes throughout the program, but some highlights: 1) Surgical Robotics has to be #1 -- some huge players will be speaking about their products, including Intuitive (perhaps you've heard news of the D5 recently?), Medtronic, Stryker, CMR Surgical, Distalmotion, Quantum Surgical ... you get the idea. 2) Boston Scientific will be talking about #PFA and the future of ablation tech. Q1 earnings showed a 70% growth in the strategic's electrophysiology business (not bad!) and 18.5% growth in the Watchman (which obviously is also part of the treatment paradigm for #AFib). What's next? 3) Super-duper pumped for the Dassault Systèmes panel with Steve Levine, Afrah Shafquat, and Ellen Roche and more discussing #insilico methods and In Silico Clinical Trials. I'm a believer that these tools are the biggest opportunity we have in life science to supercharge development, so I can't wait to hear what they discuss. 4) Nina Goodheart will be discussing how Medtronic is working to bring #structuralheart interventions to underserved communities, including women and ethnic minorities. Who wants to bet there is a discussion of the SMART trial results made public earlier this month at the American College of Cardiology annual meeting? That trial was targeted to addressing #TAVR use in smaller annuli, most directly applicable to women. 5) Two panels on sensors / connected implants, including one with Canary Medical Inc.'s Bill Hunter -- should be great to hear where they see smart implant's going. In my opinion #medtech is leaving tremendous opportunity untapped if we don't do more to integrate sensor data into our understanding of disease. Obvious hurdles to implementation (inertia being the primary one, imho), but why are we not giving clinicians and patients as much information as we can? So yeah, should be a great show! Thanks, as always, to the DeviceTalks gurus Tom Salemi, Chris Newmarker, and Kayleen Brown (and more, no doubt) for putting together a great agenda. See you there!

So refreshing to have a free event where you can collaborate and learn